Monday, February 27, 2012 8:10:01 PM
Overheard walking by a large building in New York today -
"There is nothing wrong with your trading platform. Do not attempt to adjust the picture. We are controlling transmission. If we wish to make it higher, we will bring up the volume. If we wish to make it lower, we will tune it to a whisper. We will control the horizontal. We will control the vertical. We can roll the PPS, make it flutter. We can change the daily range to a soft blur or sharpen it to crystal clarity. For the next month, sit quietly and we will control all that you see and hear. We repeat: there is nothing wrong with your trading platform. You are about to participate in a great adventure. You are about to experience the awe and mystery which reaches from the inner mind to —
The MarketMaker Limits."
"There is nothing wrong with your trading platform. Do not attempt to adjust the picture. We are controlling transmission. If we wish to make it higher, we will bring up the volume. If we wish to make it lower, we will tune it to a whisper. We will control the horizontal. We will control the vertical. We can roll the PPS, make it flutter. We can change the daily range to a soft blur or sharpen it to crystal clarity. For the next month, sit quietly and we will control all that you see and hear. We repeat: there is nothing wrong with your trading platform. You are about to participate in a great adventure. You are about to experience the awe and mystery which reaches from the inner mind to —
The MarketMaker Limits."
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
